David E. Graves

2.9k total citations
79 papers, 2.4k citations indexed

About

David E. Graves is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David E. Graves has authored 79 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 24 papers in Organic Chemistry and 15 papers in Oncology. Recurrent topics in David E. Graves's work include DNA and Nucleic Acid Chemistry (39 papers), Advanced biosensing and bioanalysis techniques (22 papers) and Cancer therapeutics and mechanisms (16 papers). David E. Graves is often cited by papers focused on DNA and Nucleic Acid Chemistry (39 papers), Advanced biosensing and bioanalysis techniques (22 papers) and Cancer therapeutics and mechanisms (16 papers). David E. Graves collaborates with scholars based in United States, Finland and New Zealand. David E. Graves's co-authors include Nichola C. Garbett, Neil Osheroff, Thomas R. Krugh, Lerena W. Yielding, William A. Denny, Charles L. Watkins, Randolph L. Rill, Randy M. Wadkins, Rich G. Carter and Jonathan B. Chaires and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

David E. Graves

73 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Graves United States 32 1.8k 757 548 221 201 79 2.4k
David Lavie Israel 36 1.6k 0.9× 515 0.7× 256 0.5× 160 0.7× 130 0.6× 230 4.4k
Julian E. Fuchs Austria 32 1.4k 0.8× 687 0.9× 274 0.5× 106 0.5× 97 0.5× 92 2.5k
Robert S. McDowell United States 28 2.8k 1.6× 969 1.3× 563 1.0× 131 0.6× 345 1.7× 44 4.3k
Cele Abad‐Zapatero United States 23 1.4k 0.8× 447 0.6× 237 0.4× 185 0.8× 352 1.8× 44 2.0k
Robert C. Kelly United States 26 1.4k 0.8× 1.5k 1.9× 321 0.6× 150 0.7× 58 0.3× 53 2.8k
Stuart W. McCombie United States 25 1.3k 0.7× 2.2k 2.9× 278 0.5× 93 0.4× 407 2.0× 86 3.7k
Hing L. Sham United States 37 2.1k 1.2× 2.0k 2.7× 558 1.0× 90 0.4× 79 0.4× 134 4.6k
Jay Wrobel United States 33 876 0.5× 1.5k 1.9× 410 0.7× 141 0.6× 167 0.8× 76 2.8k
Kent D. Stewart United States 34 1.3k 0.7× 967 1.3× 469 0.9× 34 0.2× 100 0.5× 91 3.1k
Kenji Maeda Japan 30 1.4k 0.8× 1.2k 1.5× 401 0.7× 74 0.3× 40 0.2× 113 3.1k

Countries citing papers authored by David E. Graves

Since Specialization
Citations

This map shows the geographic impact of David E. Graves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Graves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Graves more than expected).

Fields of papers citing papers by David E. Graves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Graves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Graves. The network helps show where David E. Graves may publish in the future.

Co-authorship network of co-authors of David E. Graves

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Graves. A scholar is included among the top collaborators of David E. Graves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Graves. David E. Graves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Lei, et al.. (2018). Stability of the Na+ Form of the Human Telomeric G-Quadruplex: Role of Adenines in Stabilizing G-Quadruplex Structure. ACS Omega. 3(1). 844–855. 29 indexed citations
2.
Ding, Lei, et al.. (2014). Recognition and Binding of Human Telomeric G-Quadruplex DNA by Unfolding Protein 1. Biochemistry. 53(20). 3347–3356. 31 indexed citations
3.
Tuomela, Johanna, Jouko Sandholm, Mika Kaakinen, et al.. (2013). DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells. Breast Cancer Research and Treatment. 142(3). 477–487. 34 indexed citations
4.
Tuomela, Johanna, Jouko Sandholm, Peeter Karihtala, et al.. (2012). Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer. Breast Cancer Research and Treatment. 135(2). 481–493. 58 indexed citations
5.
Aldred, Katie J., Sylvia A. McPherson, Pengfei Wang, et al.. (2011). Drug Interactions with Bacillus anthracis Topoisomerase IV: Biochemical Basis for Quinolone Action and Resistance. Biochemistry. 51(1). 370–381. 72 indexed citations
6.
Graves, David E., et al.. (2009). Interactions of Actinomycin D with Human Telomeric G-Quadruplex DNA. Biochemistry. 48(21). 4440–4447. 70 indexed citations
7.
Ilvesaro, Joanna, Melinda A. Merrell, Li Li, et al.. (2008). Toll-Like Receptor 9 Mediates CpG Oligonucleotide–Induced Cellular Invasion. Molecular Cancer Research. 6(10). 1534–1543. 75 indexed citations
8.
Graves, David E.. (2003). Drug-DNA Interactions. Humana Press eBooks. 95. 161–170. 10 indexed citations
9.
Bailly, Christian, Xiaogang Qu, David E. Graves, Michelle Prudhomme, & Jonathan B. Chaires. (1999). Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition. Chemistry & Biology. 6(5). 277–286. 36 indexed citations
10.
Zhou, Hui, et al.. (1997). Covalent Attachment of Ethidium to DNA Results in Enhanced Topoisomerase II-Mediated DNA Cleavage. Biochemistry. 36(50). 15884–15891. 26 indexed citations
11.
Graves, David E., et al.. (1995). Photoaffinity approaches to determining the sequence selectivities of DNA-small molecule interactions: actinomycin D and ethidium. Nucleic Acids Research. 23(7). 1252–1259. 2 indexed citations
12.
Bailly, Christian, et al.. (1994). Use of a Photoactive Derivative of Actinomycin To Investigate Shuffling between Binding Sites on DNA. Biochemistry. 33(29). 8736–8745. 18 indexed citations
13.
Graves, David E., et al.. (1993). Influence of DNA base sequence on the binding energetics of actinomycin D. Biochemistry. 32(22). 5881–5887. 42 indexed citations
14.
Graves, David E., et al.. (1991). Inhibition of the B to Z transition in poly(dGdC).cntdot.poly(dGdC) by covalent attachment of ethidium: kinetic studies. Biochemistry. 30(45). 10931–10937. 10 indexed citations
15.
Wadkins, Randy M. & David E. Graves. (1991). Interactions of anilinoacridines with nucleic acids: effects of substituent modifications on DNA-binding properties. Biochemistry. 30(17). 4277–4283. 14 indexed citations
16.
Graves, David E., et al.. (1991). Inhibition of the B to Z transition in poly(dGdC).cntdot.poly(dGdC) by covalent attachment of ethidium: equilibrium studies. Biochemistry. 30(45). 10925–10931. 13 indexed citations
17.
Krugh, Thomas R., David E. Graves, & Michael P. Stone. (1989). Two-dimensional NMR studies on the anthramycin-d(ATGCAT)2 adduct. Biochemistry. 28(26). 9988–9994. 27 indexed citations
18.
Wadkins, Randy M. & David E. Graves. (1989). Thermodynamics of the interactions ofm-AMSA ando-AMSA with nucleic acids: influence of ionic strength and DNA base composition. Nucleic Acids Research. 17(23). 9933–9946. 31 indexed citations
19.
Stone, Michael P., et al.. (1988). Carcinogen-Nucleic Acid Interactions: Equilibrium Binding Studies of Aflatoxins B1and B2with DNA and the Oligodeoxynucleotide d(ATGCAT)2. Journal of Biomolecular Structure and Dynamics. 5(5). 1025–1041. 23 indexed citations
20.
Yielding, Lerena W., et al.. (1979). Ethidium bromide enhancement of frameshift mutagenesis caused by photoactivatable ethidium analogs. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 63(2). 225–232. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Lavie Breakdown of academic impact, for papers by Julian E. Fuchs Breakdown of academic impact, for papers by Robert S. McDowell Breakdown of academic impact, for papers by Cele Abad‐Zapatero Breakdown of academic impact, for papers by Robert C. Kelly Breakdown of academic impact, for papers by Stuart W. McCombie Breakdown of academic impact, for papers by Hing L. Sham Breakdown of academic impact, for papers by Jay Wrobel Breakdown of academic impact, for papers by Kent D. Stewart Breakdown of academic impact, for papers by Kenji Maeda
Rankless by CCL
2026